What You Should Know:
- The U.S. Department of Health and Human Services (HHS) launches a new $50M venture capital partnership with nonprofit organization Global Health Investment Corporation (GHIC) to accelerate development and commercialization of technologies and medical products needed to respond to or prevent public health emergencies, such as pandemics, and other health security threats
- Through the BARDA Ventures program, the Biomedical Advanced Research and Development
Read More
Life Sciences | News, Analysis, Insights - HIT Consultant
PharmStars Launches Pharma-Focused Accelerator for Digital Health Startups
What You Should Know:
PharmStars today announced the launch of its global digital health accelerator to transform how pharma and startups do business. PharmStars is the first and only non-proprietary accelerator for digital health startups that wish to improve their ability to engage with pharma as clients and partners.
For its pharma members, PharmStars offers premium access to a curated group of the most promising digital health startups that align with their digital health strategy. The
Read More
Qualio Secures $50M for Quality Management System Platform for Life Sciences
What You Should Know:
- Qualio — the trusted cloud quality management system software for the entire life sciences ecosystem announced their $50M Series B funding round led by Tiger Global. Menlo Ventures also joined this round, alongside the following current Qualio investors: Frontline Ventures, MHS Capital, Operator Partners, Sorenson Ventures, and Storm Ventures.
- This latest round of funding will support Qualio’s efforts to expand accessibility of their electronic quality management
Read More
PE Firm Thoma Bravo Acquires Clinical Trial Financial Platform Greenphire – Health M&A
What You Should Know:
- Thoma Bravo, a private equity investment firm focused on the software and technology-enabled services sector announced that it has reached an agreement to acquire Greenphire, a financial lifecycle management software for clinical trials, from The Riverside Company. Financial details were not disclosed for the pending transaction.
- The acquisition, which is subject to customary regulatory approvals, is expected to close in the second quarter of this year.
-
Read More
US Orthopedic Alliance Taps 2bPrecise to Power Precision Medicine Program
What You Should Know:
2bPrecise, a precision medicine company, announced that the US Orthopedic Alliance (USOA) is leveraging 2bPrecise’ pharmacogenomics (PGx) solution to help physicians identify potentially dangerous drug-gene interactions.
- The 2bPrecise platform will deliver workflow, data management and clinical decision functionality to USOA providers ordering pharmacogenomic tests (PGx). Specifically, doctors can leverage test results to make informed decisions
Read More
UPS Healthcare Expands Specialty Pharmaceutical Offerings with End-to-End Cold Chain Capabilities
What You Should Know:
- UPS Healthcare today announced it is enhancing its specialty pharmaceutical offerings by establishing UPS Cold Chain Solutions, a comprehensive suite of cold chain technologies, best-in-class capabilities to support healthcare customers.
- UPS Cold Chain Solutions is purpose-built to provide pharmaceutical companies, healthcare providers and laboratories a full, end-to-end cold chain service offering, including storage and distribution,
Read More
AcuityMD Nabs $7M for Targeting Platform for Medical Device Companies
What You Should Know:
- AcuityMD, a platform for commercializing and improving medical devices with data announced it has raised $7M in funding led by Benchmark with participation from Ajax Health. Eric Vishria, General Partner at Benchmark will also join AcuityMD’s board of directors.
- Since launching commercially in 2020, AcuityMD has become a trusted partner within the medical device industry by creating a data platform for the entire medical device lifecycle, from sale and
Read More
CVS Health Launches Clinical Trial Services Business for Investigational COVID-19 Vaccines & Treatments
What You Should Know:
- Today, CVS Health announced the launch of a new Clinical Trial Services business, driving greater access to clinical trials across the communities CVS Health serves and creating a more efficient, convenient experience to improve participant retention and research effectiveness.
- CVS Health collaborated with the pharmaceutical industry to help facilitate clinical trials for investigational COVID-19 vaccines and treatments. Using a specially designed
Read More
Cue Health Raises $235M to Scale Connected, Molecular Diagnostic System
What You Should Know:
- Cue Health Inc., a health technology company, today announced the closing of a $235 million private financing round. The investment includes participation from new investors Perceptive Advisors, MSD Capital, and Koch Strategic Platforms, a subsidiary of Koch Industries, existing investors Johnson & Johnson Innovation – JJDC, Inc. (JJDC), Decheng Capital, CAVU Ventures, ACME Capital, and others.
- In March, the FDA granted Emergency Use Authorization for
Read More
Perceptive Advisors Closes $515M Early-Stage Biotech Fund
What You Should Know:
- Perceptive Advisors and biotech accelerator Xontogeny, focused on seed investment, incubation and collaboration, have raised their second venture capital fund, the Perceptive Xontogeny Ventures Fund II (PXV Fund II), totaling an over-subscribed $515 million. This more than triples Assets Under Management to more than $700M in less than two years.
- The
Read More
